TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-{2-{(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSU LFONYL)ETHYL]-3-OXOISOINDOLINE-4-YL}CARBOXAMIDE

Methods of treating, managing or preventing psoriasis or psoriatic arthritis are disclosed. The methods encompass the administration of cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsu lfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide, alone or in combination with a second active agent....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PETER H. SCHAFER, GEORGE W. MULLER, PATRICIA E. W. ROHANE
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Methods of treating, managing or preventing psoriasis or psoriatic arthritis are disclosed. The methods encompass the administration of cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsu lfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide, alone or in combination with a second active agent. Pharmaceutical compositions and single unit dosage forms are also disclosed. Se describen métodos de tratamiento, manejo o prevención de psoriasis o artritis psoriática. Los métodos engloban la administración de ciclopropil-N-(2-[(1S)-1-(3-etoxi-4-metoxifenil) -2-(metilsulfonil)etil]-3-oxoisoindolina-4-il}carboxamida, sola o en combinación con un segundo agente activo. También se describen composiciones farmacéuticas y formas de dosificación unitaria sencillas.